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httpcense.Abstract There are increasing data about the association between bronchial asthma and obstruc-
tive sleep apnea (OSA) is an important contributor to asthma control and can aggravate asthma
exacerbation, continuous positive airway pressure (CPAP) which is the main line of treatment in
OSA can improve asthma outcomes.
Aim of the present study: To assess the prevalence of OSA in patients with stable uncontrolled
asthma and to study the effect of CPAP treatment on the asthma condition.
Subjects and methods: Sixty subjects with uncontrolled bronchial asthma were included in the
study, mean age was 46 ± 13 years, there were female predominance (75%), all patients were not
smokers, pregnancy and patients in acute exacerbation were excluded, after detailed history taking
and physical examination pulmonary function tests and asthma control test were applied to all
patients to assess the asthma control, then polysomnography was done to all patients and those
proved to have OSA were offered CPAP treatment and followed up for 6 weeks then assessed again
for asthma control test, pulmonary function tests and day – time sleepiness.
Results: Fifteen patients out of the 60 patients included in the study proved to have OSA, Apnea
Hypopnea Index (AHI) was 23.5 ± 10.9/h of sleep, CPAP treatment improved signiﬁcantly the
AHI (from 23.5 ± 10.9 to 2.3 ± 2.1/h of sleep, p< 0.01), but there was no signiﬁcant improvement
in asthma control test or in the pulmonary functions (ACT was 13.97 ± 3.52 before CPAP and
became 14.1 ± 3.97, p> 0.05 after CPAP, FEV1% pred. was 60.1 ± 6.9 before CPAP and became
61.2 ± 6.2, p> 0.05 after CPAP.(H. Shaarawy).
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184 H. Shaarawy, N. AffaraConclusion: Obstructive sleep apnea should be screened for in all patients with uncontrolled
bronchial asthma, CPAP treatment may improve asthma quality of life but not improving the pul-
monary function tests. Larger studies are needed to fully address the impact of CPAP on asthma
condition in patient with both asthma and OSA.
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Bronchial asthma is a world – wide problem affecting about
300 million people of all ages [1], current guidelines for the
management of asthma recommend that therapy be targeted
to achieve asthma control which involves multiple components
of subjective and objective measures [1–3]. Asthma control has
been shown to improve health-related quality of life [4]. How-
ever, large community-based surveys show that this goal is
rarely achieved [5,6].
here are many reasons that can contribute in preventing
optimal control of asthma such as: non-compliance on treat-
ment, persistent exposure to certain allergen, alternative diag-
nosis as COPD or bronchiectasis, psychological disturbances,
presence of comorbid disease as allergic rhinitis or gastro-
oesophageal reﬂux, in this respect; there is growing data that
obstructive sleep apnea (OSA) is an important contributor to
asthma control, OSA is characterized by intermittent upper
airway constriction during sleep and was recently identiﬁed
as an important risk factor for frequent exacerbations in pa-
tients with difﬁcult-to-treat asthma [7]. The National Asthma
Education and Prevention Program guidelines recommend
evaluation for OSA in patients with asthma with suboptimal
control [1]. On the other hand continuous positive airway pres-
sure (CPAP) which is the main line of treatment of OSA in pa-
tients with asthma improves outcomes, including asthma
symptoms [8–10], rescue bronchodilator use [8], peak expira-
tory ﬂow rates (PEFRs) [8] and asthma-speciﬁc quality of life
assessed with validated instruments [7,11]. The aim of the pres-
ent study is to assess the prevalence of OSA in patients with
stable bronchial asthma who are not well controlled and the
effect of CPAP on the outcomes of these patients.
Subjects and methods
The present study was done in AlRashed center for allergy and
respiratory diseases, Ministry of health, Kuwait. It included 60
patients with proven diagnosis of bronchial asthma on treat-
ment and follow up in the outpatient clinic.
Inclusion criteria
(1) Long history of bronchial asthma.
(2) Proven reversible airway obstruction with spirometry
pre- and post-bronchodilatation.
(3) Asthma state is not controlled in spite of optimal treat-
ment with inhaled corticosteroids, inhaled bronchodila-
tors and bursts of oral steroids.Exclusion criteria
(1) Current smoking or history of smoking.
(2) Pregnancy.
(3) Any patient who is in acute exacerbation.All patients were subjected to
(1) History taking and physical examination.
(2) Asthma control test (ACT), it is consisted of ﬁve items;
for each item, ﬁve options were provided pertaining to
asthma control during the past 4 weeks. Each item was
scored according to a 5-point scale, and the item scores
were totaled for assessing asthma control, with higher
total scores indicating better asthma control, a score of
20 or more denotes controlled asthma, a score of 18,
19 denotes partially controlled asthma, and a score of
17 or less denotes uncontrolled asthma [12,13].
(3) Chest X-ray.
(4) Electrocardiogram (ECG).
(5) Full pulmonary function testing including spirometry
pre- and post-bronchodilatation, lung volumes and dif-
fusing capacity using Care Fusion master screen MS.
IOS 733-765.
(6) Body mass index derived from the weight and height for-
mula [14].
(7) Epworth sleepiness scale to assess presence of day-time
sleepiness [15].
(8) Over night polysomnography to screen for OSA, OSA is
diagnosed if the apnea/hypopnea index is more than 5
events per hour of sleep associated with symptoms like:
day time sleepiness, snoring, attacks of suffocation dur-
ing sleep.
(9) For those who proved to have OSA another night is
recorded with titration of nasal CPAP to treat the
OSA, then patient is followed up for 6 weeks for any
problem with the CPAP use, after 6 weeks patient is
assessed again for ESS, pulmonary function testing
and the asthma control test.
Data analysis
Statistical analysis was done using Statistical Package for So-
cial Sciences (SPSS) software version 9, all data will be tabu-
lated and presented as mean ± SD, paired student t test will
be done to compare data of the asthmatic patients proved to
have OSA before and after 6 weeks from CPAP use, and sen-
sitivity at 0.05 is accepted.
Results
From the Table 1 the demographic data of the patients showed
that the mean age of patients was 46 ± 13 years, female pa-
tient constituted about 75% of all patients, body mass index
was 30 ± 6.1 Kg/m2, none of our patients had morbid obesity,
asthma score test score was 13.97 ± 3.52, all of our patients
Table 1 Demographic and physiologic characteristics and
medical history of all patients.
Characteristic Data
Age in years 46 ± 13
Female gender 45 (75%)
Body mass index 30 ± 6.1
ACT score 13.97 ± 3.52
FEV1% pred. 60 ± 7.8
FVC% pred. 81.2 ± 3.5
FEV1/FVC 69.5 ± 6.2
FEF25–75% pred. 50.2 ± 9.4
History of chronic sinusitis 15 (25%)
History of rhinitis 48 (80%)
History of GERD 30 (50%)
ESS 9.2 ± 6.5
Snoring 45 (75%)
FEV1, forced expiratory volume in ﬁrst second; FVC, forced vital
capacity; FEF, forced expiratory ﬂow; GERD, gastroesophageal
reﬂux disease; ESS, Epworth Sleepiness Scale.
Table 2 Sleep history, polysomnography data and asthma
condition before and 6 weeks after CPAP use in group 2
patients.
Characteristic Before CPAP use After CPAP use
ESS 10.5 ± 4.3 6.4 ± 2.3*
AHI 23.5 ± 10.9 2.3 ± 2.1**
Oxygen desaturation index 25.8 ± 7.4 4.2 ± 3.2**
Arousal index 32.5 ± 6.4 10.7 ± 3.2**
FEV1% pred. 60.1 ± 6.9 61.2 ± 6.2***
FVC% pred. 79.3 ± 5.3 80.9 ± 4.8***
FEV1/FVC 70.3 ± 8.2 72.5 ± 8.5***
ACT score 13.97 ± 3.52 14.1 ± 3.97***
* Signiﬁcant difference p< 0.05.
** Highly signiﬁcant difference p< 0.01.
*** Insigniﬁcant difference p> 0.05.
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Figure 1 AHI before and after CPAP use.
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Figure 2 ACT before and after CPAP use.
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condition in the last 4 weeks, As regard pulmonary function
testing forced expiratory volume in the ﬁrst second was
60 ± 7.8% pred., forced vital capacity was 81.2 ± 3.5% pred.,
FEV1/FVC was 69.5 ± 6.2, FEF25–75 was 50.2 ± 9.4% pred.
As regard the medical history of the patients: 15 patients had
chronic sinusitis (25%), 48 patients had history of rhinitis
(80%) and 30 patients had history of GERD (50%), Epworth
Sleepiness Scale was 9.2 ± 6.5, and snoring was present in 45
patients (75%).
Polysomnography was done for all patients, and according
to the results of polysomnography the patients were divided
into 2 groups: group 1 without obstructive sleep apnea with
apnea/hypopnea index (AHI) <5/h of sleep and group 2 with
proved OSA and AHI more than 5/h of sleep, CPAP with ti-
trated in second night polysomnography for all patients in
group 2 to deﬁne the most tolerable pressure by the patient
that makes the AHI to return to normal, then the patients of
group 2 were followed up for 6 weeks then reassessed again
for sleep history and for the asthma condition, OSA was
proved by polysomnography in 15 patients, all patients ac-
cepted the CPAP trial and completed the follow up period
for 6 weeks.
From the Table 2 there was signiﬁcant improvement in day-
time sleepiness after the use of CPAP, ESS was 10.5 ± 4.3 and
became 6.4 ± 2.3 (p< 0.05), there was highly signiﬁcant
improvement in all parameters of polysomnography after
CPAP use, AHI was 23.5 ± 10.9/h of sleep before CPAP
and after use of CPAP it became 2.3 ± 2.1/h of sleep
(p< 0.01), oxygen desaturation index was 25.8 ± 7.4/h of
sleep before CPAP use and it became 4.2 ± 3.2/h of sleep after
CPAP use (p< 0.01), arousal index was 32.5 ± 6.4/h of sleep
before CPAP use and became 10.7 ± 3.2/h of sleep (p< 0.01).
As regard the asthma condition there was no signiﬁcant differ-
ence before and after CPAP use, FEV1% pred. was 60.1 ± 6.9
before CPAP use and after CPAP use it was 61.2 ± 6.2
(p> 0.05), FVC% pred. was 79.3 ± 5.3 before CPAP use
and became 80.9 ± 4.8 after CPAP use (p> 0.05), FEV1/
FVC was 70.3 ± 8.2 before CPAP use and after CPAP use it
became 72.5 ± 8.5 (p> 0.05), although there was increase innumbers of pulmonary function testing after CPAP use the dif-
ference was not statistically signiﬁcant. As regard the ACT it
186 H. Shaarawy, N. Affarawas 13.97 ± 3.52 before the use of CPAP and it became
14.1 ± 3.97 after the use of CPAP, although it was increased
the difference was not signiﬁcant (p> 0.05) and the score re-
mained 17 or below denoting non improvement in the control
of asthma Figs. 1 and 2.Discussion
The present study had 2 objectives; the ﬁrst was to assess the
prevalence of OSA in patients with uncontrolled bronchial
asthma, 15 patients out of the 60 patients included in the study
were proved to have OSA, the AHI was 23.5 ± 10.9 events/h
of sleep, the association between bronchial asthma and OSA
has many consequences on the patient, both of the 2 diseases
affect the airway of the patient, OSA affects the upper airway
by intermittent obstruction during sleep while asthma affects
mainly the medium sized and small bronchial branches of
the airways by inﬂammation of the wall, smooth muscle con-
traction and viscid secretions inside the lumen leading to par-
tial obstruction and embarrassment of respiration, many
patients with bronchial asthma have their symptoms to be
exaggerated during night with a lot of explanations were pos-
tulated for this exaggeration like GERD, increased humidity,
bed mite, decreased level of cortisone during night and in-
creases level of acetylcholine, this exaggeration of symptoms
during night has its impact on the quality of sleep of the pa-
tient and in a study done by Janson et al. in 1996 [16] they
studied 2202 patients from 3 different European countries
and they concluded that Asthma is associated with decreased
subjective quality of sleep and increased daytime sleepiness.
The net result of both diseases (OSA and asthma) will be more
affection of the respiratory system and poor quality of sleep
with its impact on day-time activity and concentration leading
to poor quality of life of the patient. Many researchers studied
this association between OSA and bronchial asthma from dif-
ferent points: Yigla et al. in 2003 [17] studied 22 patients with
uncontrolled asthma on oral steroids either continuous or in
purists, study was prospective cohort study and polysomnog-
raphy was done for all patients and they found that 21 out
of the 22 patients were having OSA and they concluded that
It may be assumed that prolonged and especially continuous
oral corticosteroid therapy in asthma increases airway collaps-
ibility leading to development of OSA. ten Brinke et al. in 2005
[7] studied 136 patients with difﬁcult to control asthma search-
ing for clinical and environmental factors potentially associ-
ated with recurrent exacerbations, they found that factors
signiﬁcantly associated with frequent exacerbations include:
severe nasal sinus disease; gastro-oesophageal reﬂux; recurrent
respiratory infections; psychological dysfunctioning; and
obstructive sleep apnoea, they concluded that recurrent exacer-
bations in asthma are associated with speciﬁc co-morbid fac-
tors that are easy to detect and that they are treatable.
Therapeutic interventions aimed at correcting these factors
are likely to reduce morbidity and medical expenditure in these
patients. Teodorescu et al. in 2009 [18] studied 244 bronchial
asthma patients to evaluate factors associated with habitual
snoring and OSA risk, from the 244 patients 37% had habitual
snoring and 40% of patients had high risk of OSA, they con-
cluded that symptoms of OSA in patients with asthma are pre-
dicted by asthma severity, coexistent GERD, and use of an
ICS in a dose-dependent fashion. The well-recognized malegender predominance for OSA symptoms is not apparent in
these patients. Further exploration of these relationships may
help to explain the increased prevalence of OSA in asthma
and provide new insights into the reported female predomi-
nance of asthma morbidity. The study gave high prevalence
of OSA in patients with asthma (40%) but the problem is that
the authors did not use polysomnography to prove the diagno-
sis of OSA in the high risk patients making a weak point in the
study. Teodorescu et al. in 2010 [19] studied 427 subjects with
asthma to evaluate the relationship between OSA risk and le-
vel of asthma control in adults, the study was done using mul-
tiple questionnaires to assess for the OSA risk and on the other
hand to assess for asthma control in the studied group, poly-
somnography was used to support the results in large group
of sleep patients, the authors concluded that high OSA risk
is signiﬁcantly associated with not-well-controlled asthma
independent of known asthma aggravators and regardless of
the asthma control questionnaire version used. Patients who
have difﬁculty achieving adequate asthma control should be
screened for OSA. From the above mentioned studies and
from the results of the present study there are a lot points of
association between bronchial asthma and OSA, asthma may
have a causative relationship to OSA through prolonged use
of steroids and female asthmatic patients are more liable to
have OSA reversing the predominance of OSA in male gender,
while on the other hand OSA can be a potential cause of inad-
equate control of bronchial asthma and increases frequency of
exacerbations through possible mechanisms such as obesity,
GERD, airway inﬂammation, or increased resistive loading
on the lower airway by partial obstruction of upper airway,
a lot of points that needs further studies, but most important
to be put in mind for clinicians that OSA must be suspected
in patients with uncontrolled bronchial asthma as presence
of OSA in addition to bronchial asthma increases the burden
on the patient. The second objective of the present study was
to assess the impact of using CPAP on the OSA and the asth-
ma condition of the patient, all 15 patients proved to have
OSA in the present study accepted the CPAP treatment and
were followed up for 6 weeks before re-assessment, CPAP im-
proved signiﬁcantly all the sleep parameters as AHI, oxygen
desaturation index and arousal index, also use of CPAP im-
proved the day time sleepiness be signiﬁcant reduction in
ESS, improvement in arousal index and day-time sleepiness
means improved day-time activity and quality of life of the pa-
tient, on the other hand there was no signiﬁcant improvement
in pulmonary function testing as regard FEV1% pred., FVC%
pred., and FEV1/FVC, although ACT was increased after
CPAP use the difference was insigniﬁcant in comparison to
values before the use of CPAP, the above mentioned results
indicate that there was improvement in OSA state and some
improvement in quality of life of the patient but without
improvement in the asthma control, Ciftci et al., in 2005 [9]
studied 43 patients with nocturnal asthma for the presence of
OSA, patients who were found to have OSA were treated with
CPAP and then followed again after 2 months, they found that
there was no improvement in pulmonary function tests after
CPAP use while asthma night time symptom scores were im-
proved signiﬁcantly after CPAP treatment. Lafond et al. in
2007 [10] studied 20 patients (11 males and 9 females) with sta-
ble asthma and OSA, they compared airway responsiveness be-
fore and after 6 weeks from CPAP use and they concluded that
nocturnal continuous positive airway pressure treatment did
Assessment of the prevalence of obstructive sleep apnea in patients with stable uncontrolled asthma, impact 187not alter airway responsiveness or forced expiratory volume in
one second in subjects with stable mild-to moderate asthma
and newly diagnosed obstructive sleep apnoea. However, noc-
turnal continuous positive airway pressure treatment did im-
prove asthma quality of life. The results of the above
mentioned studies and the results of the present study support
the hypothesis that asthma control has multiple potentials and
asthmatic patients have many co-morbidities that can aggra-
vate the asthma condition and preventing optimal control
these co-morbidities include rhinitis, sinusitis, obesity and
GERD. So, controlling one aggravating factor can help in
improving symptoms or quality of life but not improving the
pulmonary function testing.
Conclusion
Obstructive sleep apnea should be screened for in all patients
with uncontrolled bronchial asthma, CPAP treatment may im-
prove asthma quality of life but not improving the pulmonary
function tests.
Recommendation
Larger studies are needed to fully address the impact of CPAP
on asthma condition in patient with both asthma and OSA.
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